Schistosoma mansoni infection promotes SHIV clade C replication in rhesus macaques

Schistosoma mansoni infection promotes SHIV clade C replication in rhesus macaques

<p style="text-align:justify;"> Objective: To evaluate the hypothesis that parasitic infections that induce T-helper type 2 (Th2) immune responses, such as schistosomiasis, upregulate HIV-1 replication. Design: The effect of concomitant Schistosoma mansoni infection was tested in a...

Full description

Bibliographic Details
Main Authors:	Chenine, A, Buckley, K, Li, P, Rasmussen, R, Ong, H, Jiang, S, Wang, T, Augostini, P, Secor, W, Ruprecht, R
Format:	Journal article
Language:	English
Published:	Lippincott Williams & Wilkins 2005

Similar Items

Acute Schistosoma mansoni infection increases susceptibility to systemic SHIV clade C infection in rhesus macaques after mucosal virus exposure.
by: Agnès-Laurence Chenine, et al.
Published: (2008-07-01)

Schistosoma mansoni enhances host susceptibility to mucosal but not intravenous challenge by R5 Clade C SHIV.
by: Nagadenahalli B Siddappa, et al.
Published: (2011-08-01)

Variations in the Biological Functions of HIV-1 Clade C Envelope in a SHIV-Infected Rhesus Macaque during Disease Progression.
by: For Yue Tso, et al.
Published: (2013-01-01)

SHIV-1157i and passaged progeny viruses encoding R5 HIV-1 clade C env cause AIDS in rhesus monkeys
by: Siddappa Nagadenahalli B, et al.
Published: (2008-10-01)

Antigenic epitope targets of rhesus macaques self-curing from Schistosoma mansoni infection
by: Gillian M. Vance, et al.
Published: (2024-02-01)

Transmitted/founder SHIV.D replicates in the brain, causes neuropathogenesis, and persists on combination antiretroviral therapy in rhesus macaques
by: Rachel M. Podgorski, et al.
Published: (2023-08-01)

Altered gene expression in asymptomatic SHIV-infected rhesus macaques (<it>Macacca mulatta</it>)
by: Phillips Aaron T, et al.
Published: (2006-09-01)

Schistosoma mansoni vaccine candidates identified by unbiased phage display screening in self-cured rhesus macaques
by: Daisy Woellner-Santos, et al.
Published: (2024-01-01)

R5-SHIV induces multiple defects in T cell function during early infection of rhesus macaques including accumulation of T reg cells in lymph nodes.
by: Michael Santosuosso, et al.
Published: (2011-04-01)

Therapeutic efficacy of combined active and passive immunization in ART-suppressed, SHIV-infected rhesus macaques
by: Victoria E. K. Walker-Sperling, et al.
Published: (2022-06-01)

Neonatal SHIV infection in rhesus macaques elicited heterologous HIV-1-neutralizing antibodies
by: Bhavna Hora, et al.
Published: (2023-03-01)

Persistence of viral RNA in lymph nodes in ART-suppressed SIV/SHIV-infected Rhesus Macaques
by: Anthony M. Cadena, et al.
Published: (2021-03-01)

Morphine Addiction Causes Pronounced Virus Replication in Cerebral Compartment and Accelerated Onset of AIDS in SIV/SHIV-infected Indian Rhesus Macaques
by: Staprans Silvija, et al.
Published: (2005-12-01)

Differential viral rebound between lymph node and colon after treatment interruption in SHIV-infected rhesus macaques
by: D.C. Hsu, et al.
Published: (2017-12-01)

Dynamics of envelope evolution in clade C SHIV-infected pig-tailed macaques during disease progression analyzed by ultra-deep pyrosequencing.
by: For Yue Tso, et al.
Published: (2012-01-01)

Neonatal immunity associated with heterologous HIV-1 neutralizing antibody induction in SHIV-infected Rhesus Macaques
by: Sommer Holmes, et al.
Published: (2024-11-01)

Treatment of SHIV-infected, ART-suppressed rhesus macaques with bispecific HIVxCD3 DART® molecules
by: Daniel M. Gorman, et al.
Published: (2019-12-01)

Improved delivery of broadly neutralizing antibodies by nanocapsules suppresses SHIV infection in the CNS of infant rhesus macaques.
by: Jing Wen, et al.
Published: (2021-07-01)

SHIV-162P3 infection of rhesus macaques given maraviroc gel vaginally does not involve resistant viruses.
by: Athe M N Tsibris, et al.
Published: (2011-01-01)

Repressive effect of primary virus replication on superinfection correlated with gut-derived central memory CD4(+) T cells in SHIV-infected Chinese rhesus macaques.
by: Jing Xue, et al.
Published: (2013-01-01)

CD4+ T Cells Modified by the Endoribonuclease MazF Are Safe and Can Persist in SHIV-infected Rhesus Macaques
by: Naoki Saito, et al.
Published: (2014-01-01)

Analysis of multiply spliced transcripts in lymphoid tissue reservoirs of rhesus macaques infected with RT-SHIV during HAART.
by: Jesse D Deere, et al.
Published: (2014-01-01)

Immunoprofiling Correlates of Protection Against SHIV Infection in Adjuvanted HIV-1 Pox-Protein Vaccinated Rhesus Macaques
by: Pinyi Lu, et al.
Published: (2021-05-01)

An anti-HIV-1 V3 loop antibody fully protects cross-clade and elicits T-cell immunity in macaques mucosally challenged with an R5 clade C SHIV.
by: Jennifer D Watkins, et al.
Published: (2011-03-01)

Impact of Recombinant VSV-HIV Prime, DNA-Boost Vaccine Candidates on Immunogenicity and Viremia on SHIV-Infected Rhesus Macaques
by: Alice Berger, et al.
Published: (2024-03-01)

OP 6.6 – 00134 Viral Suppression in SHIV-infected Rhesus Macaques following AAVmediated Delivery of Closer-to-germline Monoclonal Antibodies
by: J. Martinez-Navio, et al.
Published: (2022-12-01)

Oral administration of a mixture of PR, RT and INT inhibitors to rhesus macaques that were persistently infected with SHIV-pr
by: Umehara Aya, et al.
Published: (2009-09-01)

Persistence of virus reservoirs in ART-treated SHIV-infected rhesus macaques after autologous hematopoietic stem cell transplant.
by: Maud Mavigner, et al.
Published: (2014-09-01)

Macaque interferon-induced transmembrane proteins limit replication of SHIV strains in an Envelope-dependent manner.
by: Amit Sharma, et al.
Published: (2019-07-01)

Circulating Plasma Exosomal Proteins of Either SHIV-Infected Rhesus Macaque or HIV-Infected Patient Indicates a Link to Neuropathogenesis
by: Partha K. Chandra, et al.
Published: (2023-03-01)

The Recombinant Maize Ribosome-Inactivating Protein Transiently Reduces Viral Load in SHIV89.6 Infected Chinese Rhesus Macaques
by: Rui-Rui Wang, et al.
Published: (2015-01-01)

PP 8.13 – 00191 Investigating the Impact of CD4 mimetic BNM-III-170 on SHIV-infected Rhesus Macaques
by: E. Viox, et al.
Published: (2022-12-01)

Assessing the impact of autologous virus neutralizing antibodies on viral rebound time in postnatally SHIV-infected ART-treated infant rhesus macaques
by: Ellie Mainou, et al.
Published: (2024-09-01)

Cooperation Between Systemic and Mucosal Antibodies Induced by Virosomal Vaccines Targeting HIV-1 Env: Protection of Indian Rhesus Macaques Against Low-Dose Intravaginal SHIV Challenges
by: Samir K. Lakhashe, et al.
Published: (2022-02-01)

Cooperation Between Systemic IgG1 and Mucosal Dimeric IgA2 Monoclonal Anti-HIV Env Antibodies: Passive Immunization Protects Indian Rhesus Macaques Against Mucosal SHIV Challenges
by: Siqi Gong, et al.
Published: (2021-08-01)

Protocol for evaluating CD8+ T cell-mediated immunity in latently SHIV-infected rhesus macaques with HIV fusion-inhibitory lipopeptide monotherapy
by: Yuting Sun, et al.
Published: (2022-09-01)

Pre-existing neutralizing antibody mitigates B cell dysregulation and enhances the Env-specific antibody response in SHIV-infected rhesus macaques.
by: Juan Pablo Jaworski, et al.
Published: (2017-01-01)

P03-10. Induction of neutralizing antibodies in Rhesus macaques following mucosal challenge with R5 tropic SHIV162P3 isolate
by: Montefiori D, et al.
Published: (2009-10-01)

Tailoring Tfh profiles enhances antibody persistence to a clade C HIV-1 vaccine in rhesus macaques
by: Anil Verma, et al.
Published: (2024-02-01)

Human Non-neutralizing HIV-1 Envelope Monoclonal Antibodies Limit the Number of Founder Viruses during SHIV Mucosal Infection in Rhesus Macaques.
by: Sampa Santra, et al.
Published: (2015-08-01)